An entrance to the CHEST 2024 conference in Boston, Massachusetts (Photo by Larry Luxner) The number of treatments for PAH continues to rise, but it still takes an an average of 3 years from symptom ...

The lifetime risk of thrombosis in patients with PNH is approximately 50%, and it tends to be found in the abdominal or cerebral veins. Patients who experience thromboses at unusual sites should be ...

Yiannis Papazoglou is one of only 40 people in the world with a mutation of the IRF2BPL gene. Foundation Aims to Help Patients With Rare Diseases—Even Before They’re Recognized The Undiagnosed ...

Top-line results are expected in the first half of 2026, with findings potentially supporting regulatory approval for in IPF. The TETON 1 study, a phase 3 randomized, placebo-controlled trial ...

Test Your Knowledge About the Diagnosis of Alpha-1 Antitrypsin Deficiency Test Your Knowledge About the Symptoms of Patients With AATD Test Your Knowledge About the Prognosis of Patients With AATD ...

Bioinformatics analysis identified overlapping differentially expressed genes between eosinophilic asthma and EGPA, highlighting shared pathogenic mechanisms. Bioinformatics analysis revealed a ...

The mean maximal mouth opening was 24.5 mm in children with SMA with no teeth and 25.66 mm in those with teeth, which represents an increase with age. Maximal mouth opening is significantly wider in ...

In the ECHELON-3 study, the brentuximab vedotin combination with lenalidomide and rituximab reduced mortality risk by 37% compared with placebo. Brentuximab vedotin (Adcetris®) has been approved by ...